Ohio State University

LIVAWAY SUITES® APPOINTS GENERAL LEGAL COUNSEL

Retrieved on: 
Wednesday, March 6, 2024
Private practice, University, Ohio State University, Tourism

SALT LAKE CITY, March 6, 2024 /PRNewswire/ -- LivAway Suites®, the rapidly expanding economy extended-stay hotel brand boasting a developer-centric platform, has announced Jeremy Raymond as its General Legal Counsel.   

Key Points: 
  • SALT LAKE CITY, March 6, 2024 /PRNewswire/ -- LivAway Suites ®, the rapidly expanding economy extended-stay hotel brand boasting a developer-centric platform, has announced Jeremy Raymond as its General Legal Counsel.
  • Over the past two years, Raymond has been instrumental in successfully managing LivAway Suites' franchise registrations (LivAway Suites is now registered in 48 of 50 states), and LivAway Suites' various trademark registrations.
  • As LivAway Suites' general legal counsel, Raymond will be responsible for providing general legal advice and guidance to the company, handling all in-house legal documentation and communications, including company contracts, analyzing legal risks, managing franchising documents and compliance, and advising on other legal issues as they arise.
  • "Adding Jeremy Raymond as General Legal Counsel is a welcomed addition to the leadership of LivAway Suites," said Mike Nielson, CEO of LivAway Suites.

Latest Updates of Viva Biotech's Portfolio Companies

Retrieved on: 
Wednesday, March 6, 2024
Fabry disease, RMB, PD, Drug development, Strong, Ohio State University, RNA, Insight Partners, Pharmacology, American College, Radiopharmaceutical, VBI, Willebrand, RTW, Pattern hair loss, GMP, Stroke, Good manufacturing practice, Therapy, Skin, GCS, Atopic dermatitis, Safety, Pharmacokinetics, Von Willebrand factor, Investment, AstraZeneca, Innovation, Groundbreaking, Patient, ARCH Venture Partners, Pharmaceutical industry

NEWARK, Calif.-- AceLink Therapeutics, Inc., invested and incubated by Viva BioInnovator (VBI), is a clinical-stage biopharmaceutical company developing next generation oral substrate reduction therapies (SRTs). Recently they announced that the findings from their Phase 1 study of AL01211 in healthy volunteers have been published in the peer-reviewed journal Clinical Pharmacology in Drug Development, a journal of the American College of Clinical Pharmacy. AL01211 is a potent, oral, glucosylceramide synthase (GCS) inhibitor being developed for the treatment of Fabry disease and Type 1 Gaucher disease.

Key Points: 
  • This continuous innovation keeps companies up to date and promotes the evolution of R&D and the success of commercialization.
  • Recently, Viva Biotech's portfolio companies have new updates.
  • NEWARK, Calif.-- AceLink Therapeutics, Inc., invested and incubated by Viva BioInnovator (VBI), is a clinical-stage biopharmaceutical company developing next generation oral substrate reduction therapies (SRTs).
  • Previously, the company had completed a $5.4 million seed funding round, with investors including Rev1 Ventures, Broadview Ventures, and Viva Biotech.

Liminal Announces Key Executive Promotions to Propel Future Growth of Its Market and Competitive Intelligence Platform and Services

Retrieved on: 
Tuesday, March 5, 2024
AI, Marketing, Growth, Ohio State University, Data science, Chemical engineering, Software as a service, Ideation, Arizona State University, Link

NEW YORK, March 5, 2024 /PRNewswire/ -- Liminal, a leading global market intelligence and strategic advisory firm, is proud to announce the promotion of two key members of its executive team.

Key Points: 
  • NEW YORK, March 5, 2024 /PRNewswire/ -- Liminal, a leading global market intelligence and strategic advisory firm, is proud to announce the promotion of two key members of its executive team.
  • Andrew Bowden has been promoted to Chief Product Officer, and Stacy Schulman has been appointed Chief Marketing Officer.
  • With a profound passion for creating knowledge pools through proprietary data sets, Andrew has led his team to develop Liminal's market intelligence platform, Link .
  • Liminal is excited to see Andrew and Stacy take on their new roles and looks forward to their contributions to the company's future growth and success.

In Honor of Black History Month, Two Scholarships for African American Students at Long Island University's College of Veterinary Medicine Have Been Established through The Brady Hunter Foundation and NYC Mayor Eric Adams' Office

Retrieved on: 
Thursday, February 29, 2024
Black History Month, New Yorker, Ohio State University, College, Long Island University, Veterinary medicine, Veterinarian, Bachelor, Health, University, Autumn, LIU, Saint John's University, Research, Student

BROOKLYN, N.Y., Feb. 29, 2024 /PRNewswire/ -- Seeking to foster diversity in the field of veterinary medicine, two new scholarships for African American students to study at Long Island University's prestigious College of Veterinary Medicine have been established through generous funding from The Brady Hunter Foundation, and in coordination with the office of New York City Mayor Eric Adams.

Key Points: 
  • The Brady Hunter Scholarship Fund will provide 50% tuition assistance for African American students with financial need from within the five boroughs of New York City at LIU's College of Veterinary Medicine on its Brookville campus.
  • "New York City's rich diversity should be reflected across every sector and industry, including veterinary medicine," said Mayor Adams.
  • "As we close Black History Month, I applaud The Brady Hunter Foundation for their efforts to help give African American students the ability to turn their career aspirations into a reality.
  • "The field of veterinary medicine faces a significant lack of diversity in the profession today, with limited opportunities for African American students," noted Josh Fox, founder of The Brady Hunter Foundation.

AI in Colleges and Universities

Retrieved on: 
Wednesday, February 28, 2024
Online, Robotics, Massachusetts Institute of Technology, Public policy, College, Student, Computer science, Air force, AI, Research, Education, Intelligence, OSU, Harvard University, Ohio State University, Parent, CSAIL, Nature, University, Faculty, Priscilla Chan, School, Machine learning, Public, Medicine, Science, The, Artificial intelligence, Artificial Intelligence Laboratory, CVO

GALES FERRY, Conn., Feb. 28, 2024 /PRNewswire/ -- Colleges and universities are at the forefront of Artificial Intelligence in research and education.

Key Points: 
  • GALES FERRY, Conn., Feb. 28, 2024 /PRNewswire/ -- Colleges and universities are at the forefront of Artificial Intelligence in research and education.
  • The Break Through Tech AI hub offers a free 18-month artificial intelligence program to a diverse range of students.
  • The college also runs an online 24-week artificial intelligence boot camp, which provides learners with the skills they need to work with AI.
  • The college also offers a short course for business owners to integrate AI in their organization.

Schaeffler Announces New Automotive Manufacturing Facility

Retrieved on: 
Monday, February 26, 2024
CNC, Light, Research, USD, Investment, Welding, City, OSU, Growth, Original equipment manufacturer, Schaeffler Group, Research and development, Plant, Ohio State University, Development, Renewable energy

Planned Investment of over USD 230 million in state-of-the-art manufacturing facility and future expansion in Ohio, USA until 2032

Key Points: 
  • Planned Investment of over USD 230 million in state-of-the-art manufacturing facility and future expansion in Ohio, USA until 2032
    HERZOGENAURACH, Germany and FORT MILL, S.C., Feb. 26, 2024 /PRNewswire/ -- Global motion technology company Schaeffler announces the expansion of its operations in the U.S. with the addition of a new manufacturing facility focused on producing automotive electric mobility solutions.
  • These jobs will lead to growth at the company's current facility in Wooster, Ohio, and the new manufacturing facility in Dover.
  • Once complete, the first phase of the facility will boast roughly 130,000 square feet of advanced manufacturing space dedicated to electric mobility solutions for the automotive industry.
  • The new manufacturing facility location is in the proximity of Schaeffler's customers, major automotive OEMs, strategic suppliers, rail, access to highways and to the company's Wooster facility, which specializes in the manufacturing of transmission systems and serves as an innovation hub for automotive electric mobility.

National Search for Development Director Begins as COL Tripp Billingsley Announces His Retirement Following 33 Years of Service at Fork Union Military Academy

Retrieved on: 
Thursday, February 22, 2024
RET, Admission, Woman, Ohio State University, 125th, Cadet Corps, Multimedia, Education, Varsity, Retirement, Mercyhurst University, University, Commandant, Family, FUMA, Fork Union Military Academy, Science, USN

FORK UNION, Va., Feb. 22, 2024 /PRNewswire-PRWeb/ -- CAPT Mark Black, USN (Ret.), the President of Fork Union Military Academy, announced this week that the school is initiating a national search to fill the role of the Academy's top development officer as COL Tripp Billingsley, the school's longtime Director of Advancement will be retiring at the end of the school year on June 30, 2024.

Key Points: 
  • ), the President of Fork Union Military Academy , announced this week that the school is initiating a national search to fill the role of the Academy's top development officer as COL Tripp Billingsley, the school's longtime Director of Advancement will be retiring at the end of the school year on June 30, 2024.
  • The Billingsley family history at Fork Union began with Joseph A. Billingsley, Sr., who graduated in the Class of 1909 when the school was still officially named Fork Union Academy.
  • Tripp Billingsley (Joseph A. Billingsley, III) first arrived at Fork Union Military Academy as a postgraduate football player in the Class of 1977, following in the footsteps of his father and grandfather before him.
  • Tripp's nephew, Jack's son Joseph B. Billingsley, is currently at Fork Union playing postgraduate basketball for Coach Bob Williams, continuing the Billingsley legacy.

New Chair and Executive Committee Members Appointed of Lymphoma Research Foundation Mantle Cell Lymphoma Consortium

Retrieved on: 
Thursday, February 15, 2024
University, SAB, Haematopoietic system, Ohio State University, LRF, Clinical professor, Health, Associate, Diagnosis, McGill University, City, Mantle cell lymphoma, MCL, Tampa General Hospital, Weill Cornell Medicine, MCLC, Internal medicine, Clinical trial, Research, Faculty, Division, MD, NHL, Cancer Institute, Cell, Executive Committee, Society, Mayo Clinic, Non-Hodgkin lymphoma, Disease, Rush University, Pharmaceutical industry

NEW YORK, Feb. 15, 2024 /PRNewswire-PRWeb/ -- The Lymphoma Research Foundation (LRF) – the nation's largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives, and patient services – is pleased to announce Tycel Phillips, MD of City of Hope and Kami Maddocks, MD of Ohio State University to the Executive Committee members and Peter Martin, MD of Weill Cornell Medicine as Chair of its Mantle Cell Lymphoma Consortium (MCLC) Executive Committee.

Key Points: 
  • "LRF's Mantle Cell Lymphoma Consortium provides a unique forum for the world's leading MCL researchers to share scientific and clinical findings, exchange ideas, and plan new collaborations," said Meghan Gutierrez, CEO of the Lymphoma Research Foundation
    The Mantle Cell Lymphoma Consortium Executive Committee helps to guide the MCLC by identifying gaps in research and patient care for this historically understudied patient population.
  • Since its inception the Mantle Cell Lymphoma Consortium brings together leading international experts to discuss the latest research findings, foster collaboration within the mantel cell lymphoma (MCL) research community, create new directions for research, and ultimately improve diagnosis and treatment for this disease.
  • "The Lymphoma Research Foundation's Mantle Cell Lymphoma Consortium provides a unique forum for the world's leading MCL researchers to share scientific and clinical findings, exchange ideas, and plan new collaborations," said Meghan Gutierrez, Chief Executive Officer of the Lymphoma Research Foundation.
  • "I'm honored to lead this vital consortium dedicated to improving outcomes for all those impacted by mantle cell lymphoma," said Dr. Martin.

Trullion Supports Geographic Expansion Welcoming Four New Leaders

Retrieved on: 
Tuesday, February 13, 2024
Professional Services, Technology, Software, Finance, Fintech, Artificial Intelligence, Accounting, CYBR, CFO, Blackline (software company), PwC, Michigan State University, CMO, College, Ohio State University, Journalism, IBM, Growth, Columbia Business School, Fortune 500, IPO, Thrive Capital, NetSuite, CyberArk, Tiger Global Management, Anaplan, Goldman Sachs, American Express, Partner, Management

The appointments support Trullion’s geographic expansion throughout the US and EMEA (Europe, the Middle East, and Africa), strengthening its executive team with new depths of experience.

Key Points: 
  • The appointments support Trullion’s geographic expansion throughout the US and EMEA (Europe, the Middle East, and Africa), strengthening its executive team with new depths of experience.
  • Scott Singerman, VP of Alliances, based in Miami, joins Trullion after spending the last five years building and leading the Global Partner Organization at Mixpanel.
  • “In addition to actively extending our geographic footprint in the US and EMEA regions, we are pleased to hire our first leader in London.
  • With the help of our growing executive team, Trullion is well-positioned to support our clients, drive growth with our partners and extend our global reach.”

The Foundation for the National Institutes of Health Launches First Public-Private Partnership for Early Detection of Preeclampsia

Retrieved on: 
Monday, February 12, 2024
Health, Family, Consumer, Other Health, Surgery, Other Science, Research, Parenting, Managed Care, General Health, Hospitals, Baby, Maternity, Science, Women, Master of Science, Bangladesh Technical Education Board, FNIH, Merck, Woman, Doctor of Philosophy, NICHD, NIH, Pregnancy, FDA, Partnership, Food, Pre-eclampsia, Mother, Ohio State University, Pappalysin-1, Letter, Risk, Human development, Cedars-Sinai Medical Center, Biomarker, Disorder, Organization, Task force, MPH, Thermo Fisher Scientific, PIGF, Child, Bill, DSM-IV codes, Mortality, George Washington University, Dietary supplement

The Foundation for the National Institutes of Health (FNIH) today announces the launch of a new public-private partnership to develop tools to identify pregnant women at high risk of early-onset preeclampsia.

Key Points: 
  • The Foundation for the National Institutes of Health (FNIH) today announces the launch of a new public-private partnership to develop tools to identify pregnant women at high risk of early-onset preeclampsia.
  • Preeclampsia is a serious pregnancy-related hypertensive disorder that can lead to maternal and neonatal deaths and long-term negative health outcomes.
  • The disorder is becoming more prevalent in the United States, with women of color more likely to be affected and experience poor outcomes.
  • Currently, preeclampsia risk is determined early in pregnancy using a combination of maternal medical history and clinical risk factors.